OTCMKTS:AVCO - Avalon Globocare Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $3.90 +0.03 (+0.78 %) (As of 01/17/2019 04:19 AM ET)Previous Close$3.87Today's Range$3.05 - $3.9052-Week Range$0.98 - $3.97Volume12,413 shsAverage Volume6,491 shsMarket Capitalization$199.67 millionP/E RatioN/ADividend YieldN/ABeta-2.03 ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Avalon GloboCare Corp., together with its subsidiaries, engages in integrating and managing healthcare services and resources in the United States. It provides medical related consulting services and develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology, as well as rehabilitation medicine. The company also develops proprietary diagnostic and therapeutic products leveraging exosome technology; and markets and distributes proprietary exosome isolation systems and related products to hospitals, as well as provides development services for hospitals. In addition, it owns and operates real property. The company has a strategic partnership Weill Cornell Medical College to co-develop technologies and bio-production of chimeric antigen receptor-T Therapy. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey. Receive AVCO News and Ratings via Email Sign-up to receive the latest news and ratings for AVCO and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Management consulting services Sub-IndustryN/A SectorBusiness Services Current SymbolOTCMKTS:AVCO Previous Symbol CUSIPN/A Webwww.avalon-globocare.com Phone732-780-4400Debt Debt-to-Equity RatioN/A Current Ratio1.27 Quick Ratio1.26Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.08 million Price / Sales268.34 Cash FlowN/A Price / Cash FlowN/A Book Value$0.11 per share Price / Book35.45Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-3,460,000.00 Net Margins-365.09% Return on Equity-81.16% Return on Assets-44.88%Miscellaneous Employees13 Outstanding Shares74,310,000Market Cap$199.67 million OptionableNot Optionable Avalon Globocare (OTCMKTS:AVCO) Frequently Asked Questions What is Avalon Globocare's stock symbol? Avalon Globocare trades on the OTCMKTS under the ticker symbol "AVCO." How were Avalon Globocare's earnings last quarter? Avalon Globocare Corp (OTCMKTS:AVCO) issued its quarterly earnings results on Tuesday, November, 13th. The company reported ($0.03) earnings per share (EPS) for the quarter. The firm earned $0.41 million during the quarter. Avalon Globocare had a negative return on equity of 81.16% and a negative net margin of 365.09%. View Avalon Globocare's Earnings History. Has Avalon Globocare been receiving favorable news coverage? Press coverage about AVCO stock has been trending positive recently, InfoTrie reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Avalon Globocare earned a media sentiment score of 2.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the company's share price in the immediate future. Who are some of Avalon Globocare's key competitors? Some companies that are related to Avalon Globocare include Apollo Medical (AMEH), The Hackett Group (HCKT), Blackrock Capital Investment (BKCC), Information Services Group (III), Gopher Protocol (GOPH), Wilhelmina International (WHLM), China Internet Nationwide Fncl Srvcs (CIFS), Pharma Bio Serv (PBSV), Lightbridge (LTBR), TSS (TSSI), Digipath (DIGP), Transatlantic Capital (TACI), HPIL (HPIL), CleanTech Innovations (SIXD) and Cartesian (CRTN). Who are Avalon Globocare's key executives? Avalon Globocare's management team includes the folowing people: Dr. David K. Jin, CEO, Pres & Director (Age 50)Ms. Luisa Ingargiola, Chief Financial Officer (Age 51)Ms. Meng Li, COO & Sec. (Age 40)Dr. Yu Zhou, Co-CEO & Director of GenExsomeDr. Bo Chen, VP of Mergers & Acquisitions How do I buy shares of Avalon Globocare? Shares of AVCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Avalon Globocare's stock price today? One share of AVCO stock can currently be purchased for approximately $3.90. How big of a company is Avalon Globocare? Avalon Globocare has a market capitalization of $199.67 million and generates $1.08 million in revenue each year. Avalon Globocare employs 13 workers across the globe. What is Avalon Globocare's official website? The official website for Avalon Globocare is http://www.avalon-globocare.com. How can I contact Avalon Globocare? Avalon Globocare's mailing address is 4400 Route 9 South Suite 3100, Freehold NJ, 07728. The company can be reached via phone at 732-780-4400. MarketBeat Community Rating for Avalon Globocare (OTCMKTS AVCO)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 75 (Vote Outperform)Underperform Votes: 76 (Vote Underperform)Total Votes: 151MarketBeat's community ratings are surveys of what our community members think about Avalon Globocare and other stocks. Vote "Outperform" if you believe AVCO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVCO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/17/2019 by MarketBeat.com StaffFeatured Article: How do investors use RSI to grade stocks?